Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
life sciences
national blog main
national top stories
sanofi
4
×
biotech
clinical trials
inclisiran
new york blog main
new york top stories
pcsk9
regeneron pharmaceuticals
san francisco blog main
san francisco top stories
alirocumab
cholesterol
deals
evolocumab
ldl
mt sinai hospital
new york
praluent
prashant vaishnava
repatha
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
cardiac
cardiovascular
cause of death
cedar-sinai
circulation
clinical studies
cobimetinib
data
david maron
What
drug
4
×
cholesterol
medicines
lowering
medco
new
wave
aces
acquire
agreed
announced
big
billion
brings
cancer
cash
ceo
company
compound
deal
despite
drugs
expensive
faces
family
fda
financial
flexible
foe
hardest
healthcare
hint
hit
hottest
hunters
inclisiran
inhibitors
ipo
key
known
Language
unset
4
×
Current search:
sanofi
×
unset
×
drug
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
